Meet the Catalysts - WARF

Meet the Catalysts

Life Sciences

Gordon Brunner
John Clapham
Daniel Getman
Brad R. Henke
Thomas Machleidt
R. Andrew Morgan
Marty Rosenberg
Karen Seibert
Robert Weiland
Paul Weiss

Clean Technology

William Banholzer
Douglas Cameron
Spencer Maughan
Laura R. Nereng
Patrick Sajbel
Jason Smith
Alex Tang
Candace Wheeler

Computer Science and Engineering

Keith Lobo
Gregory Robinson
Tim Rueth
Paul Shain
David Smukowski
Jeffrey Thomas

Food and Agriculture

Jack Kaltenberg
Bryan Renk
Kevin Bacon
Paul Stewart
Greg Sumner
Kathy Swords

Medical Devices

Gregg Fergus
Michael Liang
Thomas "Rock" Mackie
Walter O'Neill
Matthew Ogle
Peter Tong

Life Sciences Catalysts

Gordon Brunner

Gordon Brunner

  • Retired Chief Technology Officer and member of the Board, Procter and Gamble; WARF Board Trustee
  • Forty year career at Proctor and Gamble, ultimately serving as senior vice president of research and development, during which he instituted many major changes in the company's global innovation process and saw development of seven new multibillion dollar brands, including Actonel for osteoporosis
  • MBA (Xavier University); B.S. Biochemical Engineering (UW–Madison)
John Clapham

John Clapham

  • Chief Executive Officer, PSC Biotech
  • Worked for the U.S. Department of Defense, Lockwood Greene Engineers, Johnson & Johnson and Fluor Daniel before founding PSC Biotech
  • B.S. Chemical Engineering (University of Rhode Island)
Daniel Getman

Daniel Getman

  • Retired President, Kansas City Area Life Sciences Institute
  • Served as vice president at Pfizer Global Research and Development and as director for St. Louis Laboratories
  • Ph.D. Organic Chemistry (University of Minnesota); B.S. Chemistry (State University of New York at Buffalo)
Brad Henke

Brad R. Henke

  • President, Opti-Mol Consulting LLC
  • Served as a senior director of chemistry at GlaxoSmithKline and was a program team leader for research teams that produced 10 clinical drug candidates
  • Ph.D. Synthetic Organic Chemistry (University of Illinois); B.S. Chemistry (Miami University)
Thomas Machleidt

Thomas Machleidt

  • Senior Scientist, Promega
  • Held positions in research and development at Life Technologies, Ansata Therapeutics and Johnson & Johnson Pharmaceutical Research and Development
  • Ph.D. Immunology (Technical University of Munich in Germany); M.S. Biology (University of Tuebingen)
R. Andrew Morgan

R. Andrew Morgan

  • Executive Vice President, Regulatory Affairs and Quality Operations, Zurex Pharma and Zurex PharmAgra
  • More than 25 years experience in the pharmaceutical industry, including as a vice president at Genzyme Corp., a vice president at Bone Care International, a director for Celltech Pharmaceuticals and a registered pharmacist
  • B.S. Pharmacy (SWOSU School of Pharmacy)
Marty Rosenberg

Marty Rosenberg

  • Retired Chief Scientific Officer, Promega Corp.
  • Served as a section chief at the National Cancer Institute of the National Institutes of Health; worked for 20 years in the pharmaceutical industry, ultimately serving as a senior vice president and director of research and development for SmithKline Beecham and GlaxoSmithKline
  • Ph.D. (Purdue University); B.A. (University of Rochester)
Karen Seibert

Karen Seibert

  • Professor of Pathology and Immunology, Washington University School of Medicine
  • Worked in the pharmaceutical industry for nearly 20 years, including as vice president of research at Pfizer, and is one of the principal investigators who identified the arthritis and pain drug Celebrex®
  • Ph.D. (Vanderbilt University School of Medicine); M.S. Pharmacology (University of Toledo); B.S. Biological Sciences (Northwestern University)
Robert Weiland

Robert Weiland

  • Chief Commercial Officer, Pacira Pharmaceuticals Inc.
  • Developed strategy and managed health care businesses for Baxter, Takeda, Abbott and American Hospital Supply
  • MBA (The Wharton School at the University of Pennsylvania); B.S. Accounting & Business (DeSales University, Pennsylvania)
Paul Weiss

Paul Weiss

  • Managing Director, Venture Investors
  • More than 20 years experience in the biotech and pharmaceutical industries, including as president of the Gala Biotech business unit of Cardinal Health
  • MBA (UW–Madison); Ph.D. Biochemistry (UW–Madison); B.S. Biochemistry (Carleton University, Ontario)

back to top >


Clean Technology Catalysts

William Banholzer

William Banholzer

  • Research Professor, chemical and biological engineering department and Wisconsin Energy Institute, UW–Madison
  • Formerly chief technology officer and executive vice president at The Dow Chemical Company; 22 year career at General Electric Co.; elected to the U.S. National Academy of Engineering in 2002
  • Ph.D., M.S. Chemical Engineering (University of Illinois); B.S. Chemistry (Marquette University)
Douglas Cameron

Douglas Cameron

  • Co-President and Director, First Green Partners
  • Professor of chemical engineering at UW–Madison for 15 years and held various positions in the clean tech, biotech and investment industries, including manager, director and chief science adviser at Piper Jaffray
  • Ph.D. Biochemical Engineering (Massachusetts Institute of Technology); B.S.E. Biomedical Engineering (Duke University)
Spencer Maughan

Spencer Maughan

  • Partner, Finistere Ventures
  • Former entrepreneur-in-residence with Kleiner Perkins Caufield and Byers and investor at Venrock; more than 10 years experience in the life sciences, including research that led to a new set of compounds for the treatment of malaria
  • Ph.D., B.S. (University of Melbourne); MBA (Stanford University)
Laura Nereng

Laura R. Nereng

  • Sustainability Leader, 3M Electronics and Energy Business Group
  • More than 25 years experience at 3M, serving in various roles including engineering, product development/R&D, manufacturing, marketing, sales, product management and new business development
  • MBA (Cardinal Stritch University); B.S. Chemical Engineering (University of Notre Dame)
Patrick Sajbel

Patrick Sajbel

  • Business Development Director, LanzaTech
  • More than 35 years of global process and catalyst experience in the energy industry
  • KMI (Kellogg Management Institute, Northwestern University); B.S. Chemical Engineering (UW–Madison)
Jason Smith

Jason Smith

  • President, Peak Ridge Capital Group
  • Currently serves as a sitting director of multiple early-stage companies, including Wisconsin companies Frozen Codebase, LocalDirt, Broadjam.com, New River Technologies, Xolve and Zurex PharmAgra
  • J.D. (New England School of Law); B.S. (UW–Madison)
Alex Tang

Alex Tang

  • Licensing and Commercialization Manager, Gas Technology Institute
  • More than 10 years commercialization and venture capital experience, including as a mentor at Surge Accelerator, founding staff of Clean Energy Trust and co-founder of Invention Bridge
  • MBA (University of Chicago); M.S., B.S. Mechanical Engineering (University of Illinois-Urbana-Champaign)
Candace Wheeler

Candace Wheeler

  • Technical Fellow, GM Research & Development
  • Thirty year career at General Motors; currently serves on the advisory board of many leading energy and biofuels organizations
  • Ph.D. Pharmacology and Toxicology (Wayne State University School of Medicine); B.S. Chemistry (Wheaton College)
back to top >

Computer Science and Engineering Catalysts

Keith Lobo

Keith Lobo

  • Investor/Entrepreneur, former general partner of Fremont Ventures; WARF Board Trustee
  • Worked in the electronics and venture capital industries for 30 years, including as president, chief executive officer and a director at Quickturn Design Systems
  • MBA Finance and International Business (UW–Madison); M.E. Engineering (Stevens Institute of Technology, New Jersey)
Gregory Robinson

Gregory Robinson

  • General Partner, 4490 Ventures
  • More than 20 years of operating and venture capital experience, including as a partner at Peninsula Ventures and a co-founder and chief operating officer at Cogent Technologies
  • MBA (Tuck School of Business at Dartmouth); B.S. Economics (Arizona State University)
Tim Rueth

Tim Rueth

  • Investor/Advisor and Entrepreneur-in-Residence
  • Fourteen years experience as an engineer in large high-tech enterprises; 18 years experience as a senior executive, entrepreneur and venture investor/advisor in high-tech startups
  • B.S, M.S. Electrical Engineering (UW–Madison)
Paul Shain

Paul Shain

  • Chief Executive Officer, Singlewire Software
  • Served as senior vice president and executive committee member of CDW and chief executive officer of Berbee Information Networks Corp.
  • MBA Finance (UW–Madison); BBA Finance (UW–Madison)
David Smukowski

David Smukowski

  • Chief Executive Officer, Simco Holdings; WARF Board Trustee
  • Served as the chief executive officer of Sensors in Motion and founded several companies, including MessageGate, Exostar and Crystallia; current member of the advisory boards for the University of Washington Burke Center for Entrepreneurship and University of California-Santa Barbara Technology Management Program
  • B.S. Civil and Environmental Engineering (UW–Madison)
Jeffrey Thomas

Jeffrey Thomas

  • Consultant
  • Held several posts in engineering management, including senior vice president of engineering at Sun Microsystems and vice president of engineering at Huawei Technologies
  • B.S. Electrical Engineering (UW–Madison)
back to top >

Food and Agriculture Catalysts

Jack Kaltenberg

Jack Kaltenberg

  • Owner/Partner, Partners in Production LLC
  • More than 40 years experience in the agriculture industry, including as president of Kaltenberg Seed Farms
  • B.S. Agronomy (UW–Madison)
Bryan Renk

Bryan Renk

  • Associate Director of Commercialization, University of Arkansas, Division of Agriculture
  • Former executive director of BioForward; served as president and CEO of aOva Technologies
  • B.S., M.S. Meat and Animal Science, Muscle Biology (UW–Madison)
Kevin Bacon

 Kevin Bacon

  • Integrated Supply Chain Consultant in the food industry
  • Over 30 years of food industry experience in large CPG companies, Oscar Mayer, Kraft Foods, & Mondelez International
  • B.S. Agriculture; M.S. in Meat and Animal Science (UW-Madison) and Executive MBA (University of Iowa) 
Paul Stewart

 Paul A. Stewart

  • Managing Director of PASCO Ventures LLC
  • Over 25 years of executive & leadership experience across multiple industries
  • B.S. Agricultural Business Management (Purdue University); MBA (Harvard Business School)
Greg Sumner

Greg Sumner

  • President, GJS Consulting LLC
  • Has over 30 years of experience in animal health industry at Merck Animal Health, Intervet Animal Health and Schering-Plough Animal Health
  • B.A., B.S., and DVM (University of Illinois)
Kathy Swords

Kathy Swords

  • Consultant, LaVista Ag, LLC specializing in intellectual property, agricultural biotechnology strategy and product development
  • Scientific background is focused on plant-microbe interactions and crop defense
  • B.A. and M.A. (UC-Santa Barbara) Cellular Biology; MBA (Boise State University); Ph.D. (University of Colorado-Boulder) Molecular, Cellular and Developmental Biology

back to top >

Medical Devices

Gregg Fergus

Gregg Fergus

  • Chief Executive Office/Chief Commercial Officer, 4 Catalyzer
  • Served as president and chief operating office at Ion Torrent
  • B.S. Bacteriology (UW–Madison)
Michael Liang

Michael Liang

  • Partner, Baird Venture Partners
  • Served as a director of research and development at Cortek and was responsible for the development of three spinal orthopedic products
  • Ph.D. Biophysical Chemistry (Stanford University); B.S. Bioorganic Chemistry (University of California, Berkeley)
Thomas Mackie

Thomas "Rock" Mackie

  • Senior Relationship Liaison, Medical Devices, Morgridge Institute for Research
  • Co-founded Geometrics Corp., now part of Philips Healthcare, and TomoTherapy, recently acquired by Accuray; currently serves as president of the Medical Physics Foundation
  • Ph.D. Physics (University of Alberta-Edmonton); B.Sc. Physics (University of Saskatchewan)
Walter O'Neill

Walter O’Neill

  • Manager, Esaote North America, MRI Division
  • Worked in the diagnostic imaging industry for 30 years; held senior positions in the medical imaging businesses of GE Healthcare, LUNAR Corporation and Philips Medical Systems
  • B.S. Biology (SUNY Cortland); B.S. Health Science (SUNY Stony Brook)
Matthew Ogle

Matthew Ogle

  • President & Founder, MIVI Neuroscience
  • Worked in the medical devices industry for more than 17 years, founded three startup companies including Lumen Biomedical, commercialized nine products and filed more than 50 patents
  • M.S. Materials Science (University of Minnesota); B.A. Chemistry (St. John's University)
Peter Tong

Peter Tong

  • Corporate Director/Adviser for various entities engaged in the medical technology sector; WARF Board Trustee
  • Helped establish the UW–Madison Technology Enterprise Cooperative (UW-TEC), funded the Tong Prototype Prize and Loan Program and has been involved in the creation of a number of medical technology business enterprises, including T & T Technology Corporation and Medical Data Corporation
  • M.S. Electrical Engineering (UW–Madison); B.S. Electrical Engineering (Kansas State University)
back to top >